Steroid myopathy is a non-inflammatory toxic myopathy that occurs as side effect of exogenous and endogenous glucocorticoid excess. The purpose of this review is to examine issues that limit our understanding of this myopathy with respect to nosology, etiopathogenesis, conditioning factors, and muscle fiber selectivity. We suggest that if more data were available on these issues, the understanding of steroid myopathy would be enhanced substantially, thus allowing an early detection of its occurrence (before the appearance of clinical or laboratory signs) and a proper treatment of the patients.

Steroid myopathy: some unresolved issues

MINETTO, Marco Alessandro;LANFRANCO, Fabio;MOTTA, GIOVANNA;ALLASIA, Stefano;ARVAT, Emanuela;
2011-01-01

Abstract

Steroid myopathy is a non-inflammatory toxic myopathy that occurs as side effect of exogenous and endogenous glucocorticoid excess. The purpose of this review is to examine issues that limit our understanding of this myopathy with respect to nosology, etiopathogenesis, conditioning factors, and muscle fiber selectivity. We suggest that if more data were available on these issues, the understanding of steroid myopathy would be enhanced substantially, thus allowing an early detection of its occurrence (before the appearance of clinical or laboratory signs) and a proper treatment of the patients.
2011
34
5
370
375
Minetto MA; Lanfranco F; Motta G; Allasia S; Arvat E; D’Antona G
File in questo prodotto:
File Dimensione Formato  
Minetto et al. JEI 2011.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 338.65 kB
Formato Adobe PDF
338.65 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/82012
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 54
  • ???jsp.display-item.citation.isi??? 46
social impact